SLC44A1 and lung adenocarcinoma: CTL1 inhibitors significantly block choline uptake in the lung adenocarcinoma cell lines A549, H1299, and SPC-A-1, and their ability to block uptake was closely associated with their efficacy in reducing cell proliferation (143).